Strategikon Pharma
Latest round
- Series A
Last raised
- Apr 2021
Total raised
- Undisclosed
Investors
- 8
About Strategikon Pharma
Strategikon Pharma Inc.Founded in 2016 in San Rafael, US, Strategikon Pharma Inc. focuses on providing advanced software solutions for clinical trials. The company was co-founded by Anca Copaescu and Paulo Carvalho, with Anca Copaescu currently serving as CEO.Strategikon delivers a suite of AI-driven software-as-a-service (SaaS) solutions tailored for the clinical trials and pharmaceutical industries. Its flagship products include VISION, Clinical Maestro, CORE, and LEAD, designed to streamline and enhance various aspects of clinical study management. VISION acts as a centralized hub for vendor management, providing real-time insights into vendor qualifications and performance. Clinical Maestro automates budgeting, contract management, and vendor selection, while CORE specializes in precise clinical trial budgeting. LEAD automates workflows related to clinical study budgets, enabling users to monitor project timelines and compliance.Strategikon operates on a subscription-based revenue model, deriving income from fees associated with the use of its products, including VISION, Clinical Maestro, CORE, and LEAD. Clients typically engage in long-term partnerships through annual subscriptions that provide access to a comprehensive range of features.In April 2021, Strategikon Pharma Inc. The company plans to utilize these funds to expand its global presence in Europe and Asia, develop new applications, and enhance the existing Clinical Maestro™ ecosystem. Furthermore, it aims to broaden its professional services to ensure a superior customer experience.
Who invested in Strategikon Pharma
8 investors across 1 round
See all investors in Strategikon Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 22, 2021
Amount
Undisclosed
Investors
Questions about Strategikon Pharma
Who invested in Strategikon Pharma?
Strategikon Pharma has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Strategikon Pharma raised?
Strategikon Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Strategikon Pharma last raise money?
Strategikon Pharma's most recent round on record is a Series A, in Apr 2021.
What does Strategikon Pharma do?
Strategikon Pharma is a healthcare it company.
Where is Strategikon Pharma headquartered?
Strategikon Pharma is headquartered in San Rafael, US.
Which VCs invest in companies like Strategikon Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Strategikon Pharma's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series A
Raising like Strategikon Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.